Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

354 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The urgent need to improve the tools to assess clinical benefit and value of cancer treatment.
Sobrero A, Puccini A, Bregni G, Bruzzi P. Sobrero A, et al. Among authors: bruzzi p. Eur J Cancer. 2017 Sep;83:324-328. doi: 10.1016/j.ejca.2017.04.029. Epub 2017 Jul 24. Eur J Cancer. 2017. PMID: 28751070
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
Del Mastro L, Levaggi A, Michelotti A, Cavazzini G, Adami F, Scotto T, Piras M, Danese S, Garrone O, Durando A, Accortanzo V, Bighin C, Miglietta L, Pastorino S, Pronzato P, Castiglione F, Landucci E, Conte P, Bruzzi P. Del Mastro L, et al. Among authors: bruzzi p. Breast Cancer Res Treat. 2016 Jan;155(1):117-26. doi: 10.1007/s10549-015-3655-1. Epub 2015 Dec 10. Breast Cancer Res Treat. 2016. PMID: 26661403 Clinical Trial.
Treatment with aromatase inhibitors and markers of cardiovascular disease.
Blondeaux E, Musio D, Bruzzi P, Lambertini M, Gazzola V, Poggio F, Vecchio S, Levaggi A, D'Alonzo A, Perfumo MC, Bighin C, Giraudi S, Palombo D, Del Mastro L. Blondeaux E, et al. Among authors: bruzzi p. Breast Cancer Res Treat. 2016 Nov;160(2):261-267. doi: 10.1007/s10549-016-3985-7. Epub 2016 Sep 23. Breast Cancer Res Treat. 2016. PMID: 27663435
Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures.
Bertoglio S, Faccini B, Lalli L, Cafiero F, Bruzzi P. Bertoglio S, et al. Among authors: bruzzi p. J Surg Oncol. 2016 May;113(6):708-14. doi: 10.1002/jso.24220. Epub 2016 Mar 29. J Surg Oncol. 2016. PMID: 27020965 Clinical Trial.
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumors.
Sobrero AF, Pastorino A, Sargent DJ, Bruzzi P. Sobrero AF, et al. Among authors: bruzzi p. Clin Cancer Res. 2015 Mar 1;21(5):1036-43. doi: 10.1158/1078-0432.CCR-14-1505. Epub 2014 Sep 17. Clin Cancer Res. 2015. PMID: 25231398
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.
Gennari A, Amadori D, De Lena M, Nanni O, Bruzzi P, Lorusso V, Manzione L, Conte PF. Gennari A, et al. Among authors: bruzzi p. J Clin Oncol. 2006 Aug 20;24(24):3912-8. doi: 10.1200/JCO.2006.06.1812. J Clin Oncol. 2006. PMID: 16921042 Clinical Trial.
Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval.
Sobrero A, Bruzzi P. Sobrero A, et al. Among authors: bruzzi p. J Clin Oncol. 2009 Dec 10;27(35):5868-73. doi: 10.1200/JCO.2009.22.4162. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826122 No abstract available.
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.
Gronchi A, De Paoli A, Dani C, Merlo DF, Quagliuolo V, Grignani G, Bertola G, Navarria P, Sangalli C, Buonadonna A, De Sanctis R, Sanfilippo R, Dei Tos AP, Stacchiotti S, Giorello L, Fiore M, Bruzzi P, Casali PG. Gronchi A, et al. Among authors: bruzzi p. Eur J Cancer. 2014 Mar;50(4):784-92. doi: 10.1016/j.ejca.2013.11.021. Epub 2013 Dec 5. Eur J Cancer. 2014. PMID: 24316063 Clinical Trial.
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial.
Del Mastro L, De Placido S, Bruzzi P, De Laurentiis M, Boni C, Cavazzini G, Durando A, Turletti A, Nisticò C, Valle E, Garrone O, Puglisi F, Montemurro F, Barni S, Ardizzoni A, Gamucci T, Colantuoni G, Giuliano M, Gravina A, Papaldo P, Bighin C, Bisagni G, Forestieri V, Cognetti F; Gruppo Italiano Mammella (GIM) investigators. Del Mastro L, et al. Among authors: bruzzi p. Lancet. 2015 May 9;385(9980):1863-72. doi: 10.1016/S0140-6736(14)62048-1. Epub 2015 Mar 2. Lancet. 2015. PMID: 25740286 Clinical Trial.
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
Bruzzi P, Del Mastro L, Sormani MP, Bastholt L, Danova M, Focan C, Fountzilas G, Paul J, Rosso R, Venturini M. Bruzzi P, et al. J Clin Oncol. 2005 Aug 1;23(22):5117-25. doi: 10.1200/JCO.2005.02.106. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955906
354 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback